Review



5, 10, 15, 20-tetrakis (1-methylpyridinium-4-yl) porphyrin (tmpyp4)  (CEM Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    CEM Corporation 5, 10, 15, 20-tetrakis (1-methylpyridinium-4-yl) porphyrin (tmpyp4)
    Targeting moiety approaches used to enhance NP PSs active drug delivery systems in tumours.
    5, 10, 15, 20 Tetrakis (1 Methylpyridinium 4 Yl) Porphyrin (Tmpyp4), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmpyp4/g+quadruplex++tmpyp4/pmc06222717-19-52-21
    Average 90 stars, based on 1 article reviews
    5, 10, 15, 20-tetrakis (1-methylpyridinium-4-yl) porphyrin (tmpyp4) - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy"

    Article Title: Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy

    Journal: Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry

    doi: 10.3390/molecules23102628

    Targeting moiety approaches used to enhance NP PSs active drug delivery systems in tumours.
    Figure Legend Snippet: Targeting moiety approaches used to enhance NP PSs active drug delivery systems in tumours.

    Techniques Used: Over Expression, In Vitro, In Vivo, Inhibition, Irradiation

    Related Articles

    other:

    Article Title: Self-assembly of a bifunctional DNA carrier for drug delivery.
    Article Snippet: Herein, we propose a simple method for combining two functional DNA groups, such that one group is capable of recognizing the target cell, while a complementary group acts as a drug delivery carrier.. This novel G-quadruplex–aptamer– drug platform takes advantage of the target-recognition function of a DNA aptamer and the drug-loading ability of a G-quadruplex.. The design and engineering are based on DNA selfassembly.

    Article Title: Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy
    Article Snippet: DNA G-quadruplex Aptamer , Direct , Sgc8 leukemia aptamer, which can specifically bind to protein tyrosine kinase 7 (PTK7) receptor , CEM cells CEM (CCL-119, T-cell line, human & Ramos (CRL-1596, B-cell line, human Burkitt’s lymphoma) & Cervical cancer (HeLa) mouse models , In vitro & in vivo , 5, 10, 15, 20-tetrakis (1-methylpyridinium-4-yl) porphyrin (TMPyP4) , Zr-based nanoscale metal-organic frameworks (Zr-NMOFs) , Nanosystem induced 90% cell death of targeted cells & maintained more than 76% tumour inhibition within the entire experimental period. , [ ] .

    Article Title: Targeted bioimaging and photodynamic therapy nanoplatform using an aptamer-guided G-quadruplex DNA carrier and near-infrared light.
    Article Snippet: Photodynamic therapy (PDT) has recently emerged as an effective, noninvasive, and economical treatment for diseases including cancers.. Traditional PDT suffers mainly from having an insufficient number of photons penetrating the tissue and preferentially targeting cancerous tissues with photosensitizers.. Therefore, it is necessary to construct a method for controllable singlet-oxygen (O2) generation (SOG) with high selectivity and accurate localization to provide more efficient PDT with fewer side effects.

    In Vitro:

    Article Title: Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures.
    Article Snippet: Due to the limitations of conventional cancer treatment methods, nanomedicine has appeared as a promising alternative, allowing improved drug targeting and decreased drug toxicity.. In the development of cancer nanomedicines, among various nanoparticles (NPs), DNA nanostructures are more attractive because of their precisely controllable size, shape, excellent biocompatibility, programmability, biodegradability, and facile functionalization.. Aptamers are introduced as single-stranded RNA or DNA molecules with recognize their corresponding targets.

    Control:

    Article Title: Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures.
    Article Snippet: Due to the limitations of conventional cancer treatment methods, nanomedicine has appeared as a promising alternative, allowing improved drug targeting and decreased drug toxicity.. In the development of cancer nanomedicines, among various nanoparticles (NPs), DNA nanostructures are more attractive because of their precisely controllable size, shape, excellent biocompatibility, programmability, biodegradability, and facile functionalization.. Aptamers are introduced as single-stranded RNA or DNA molecules with recognize their corresponding targets.

    Irradiation:

    Article Title: Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures.
    Article Snippet: Due to the limitations of conventional cancer treatment methods, nanomedicine has appeared as a promising alternative, allowing improved drug targeting and decreased drug toxicity.. In the development of cancer nanomedicines, among various nanoparticles (NPs), DNA nanostructures are more attractive because of their precisely controllable size, shape, excellent biocompatibility, programmability, biodegradability, and facile functionalization.. Aptamers are introduced as single-stranded RNA or DNA molecules with recognize their corresponding targets.



    Similar Products

    94
    MedChemExpress tmpyp4
    Tmpyp4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmpyp4/Balapiravir/pm42204560-73-68-70
    Average 94 stars, based on 1 article reviews
    tmpyp4 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    91
    Selleck Chemicals tmpyp4
    Tmpyp4, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmpyp4/TMPyP4+tosylate/pm41803560-304-32-35
    Average 91 stars, based on 1 article reviews
    tmpyp4 - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    86
    Merck & Co tmpyp4
    RBM3 PE skipping increases on destabilization of rG4 structures. See also Figure S1 (A) Schematic of the experimental design in i3-neurons to evaluate the effect of <t>TMPyP4</t> in RBM3 PE inclusion (B) RT-PCR of RBM3 mRNA (Exon 2–4) in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms. (C) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (B). (D) qRT-PCR quantifying the PSI values of RBM3 PE relative to RBM3 mRNA in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM). (E) Schematic of the experimental design in HeLa to evaluate the effect of TMPyP4 in RBM3 PE inclusion (top). RT-PCR of RBM3 mRNA (Exon 2–4) in HeLa at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms (bottom). (F) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (E). Data information: N = 3 biological replicates. Mean ± SEM; ns (not significant), *(P<0.05), **(P<0.01); ***(P<0.001); one-way ANOVA with multiple comparisons.
    Tmpyp4, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmpyp4/tmpyp4/bio_rxiv__64898__2025__12__18__694734-135-10-11
    Average 86 stars, based on 1 article reviews
    tmpyp4 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    Millipore tmpyp4 (catalog no. [cat#] 613560)
    RBM3 PE skipping increases on destabilization of rG4 structures. See also Figure S1 (A) Schematic of the experimental design in i3-neurons to evaluate the effect of <t>TMPyP4</t> in RBM3 PE inclusion (B) RT-PCR of RBM3 mRNA (Exon 2–4) in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms. (C) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (B). (D) qRT-PCR quantifying the PSI values of RBM3 PE relative to RBM3 mRNA in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM). (E) Schematic of the experimental design in HeLa to evaluate the effect of TMPyP4 in RBM3 PE inclusion (top). RT-PCR of RBM3 mRNA (Exon 2–4) in HeLa at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms (bottom). (F) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (E). Data information: N = 3 biological replicates. Mean ± SEM; ns (not significant), *(P<0.05), **(P<0.01); ***(P<0.001); one-way ANOVA with multiple comparisons.
    Tmpyp4 (Catalog No. [Cat#] 613560), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmpyp4/tmpyp4/10__1016_slash_j__xcrp__2025__102560-145-1-17
    Average 90 stars, based on 1 article reviews
    tmpyp4 (catalog no. [cat#] 613560) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    eMolecules Inc tmpyp4
    Effects of <t>TMPyP4</t> and TMPyP2 treatments on Thermotoga and Pseudothermotoga growth, protein content, and ribosomal gene expression. ( A ) Schematic representation of the experimental setup, showing treatment with TMPyP4 or TMPyP2 and incubation for 6 and 24 h. ( B ) Bacterial growth measured as OD 600 after 6 and 24 h. ( C ) Total protein content after 6 and 24 h of treatment. Relative expression levels of ribosomal genes 5S ( D ), 16S ( E ), and 23S ( F ) determined by qPCR at 6 and 24 h post-treatment. Data are shown as mean ± standard error (SE). Statistical significance is indicated as * P < 0.05, ** P < 0.01, *** P < 0.001 (Student's t test). Abbreviations: mar: T. maritima , elf: T. elfii .
    Tmpyp4, supplied by eMolecules Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmpyp4/tmpyp4/pmc11780868-82-3-4
    Average 90 stars, based on 1 article reviews
    tmpyp4 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GlpBio Technology Inc tmpyp4 tosylate
    Confirmation of antibacterial activity. A The antibacterial activities of NMM, TMPyP2, BRACO19, <t>TMPyP4,</t> and Thioflavin T against SAUSA300 were examined by measuring cell growth in terms of OD at 600 nm. B, C SAUSA300 cell growth assessed as CFU/mL ( B ); representative sheep-blood agar plates showing the appearance of colonies during CFU enumeration ( C ). D , E Comparative killing kinetics of vancomycin (Van), Tetracycline (Tet), and NMM against SAUSA300 based on CFU/mL at 1.0 × ( D ); and 10 × ( E ) MIC of Van, Tet, NMM, and 0.05% Triton X-100 at different time points (0 to 12 h). F Comparative live/dead assay of SAUSA300 with 1 × MIC of NMM (5 µM) and Van (0.6 µM) using confocal microscopy, showing the proportion of live/dead SAUSA300 cells. SYTO9 and PI were used to stain the number of total and dead cells as green-fluorescent and red-fluorescent cells, respectively. All experiments were performed in triplicate and the average data was plotted with standard deviation. Significance of the data was analyzed using Student’s t -test. p -values less than 0.05 were considered significant (ns = non-significant p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.005, and **** p < 0.0001)
    Tmpyp4 Tosylate, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmpyp4/tmpyp4+tosylate/pmc11796246-42-23-26
    Average 90 stars, based on 1 article reviews
    tmpyp4 tosylate - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    RBM3 PE skipping increases on destabilization of rG4 structures. See also Figure S1 (A) Schematic of the experimental design in i3-neurons to evaluate the effect of TMPyP4 in RBM3 PE inclusion (B) RT-PCR of RBM3 mRNA (Exon 2–4) in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms. (C) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (B). (D) qRT-PCR quantifying the PSI values of RBM3 PE relative to RBM3 mRNA in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM). (E) Schematic of the experimental design in HeLa to evaluate the effect of TMPyP4 in RBM3 PE inclusion (top). RT-PCR of RBM3 mRNA (Exon 2–4) in HeLa at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms (bottom). (F) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (E). Data information: N = 3 biological replicates. Mean ± SEM; ns (not significant), *(P<0.05), **(P<0.01); ***(P<0.001); one-way ANOVA with multiple comparisons.

    Journal: bioRxiv

    Article Title: RNA secondary structures modulate hnRNPH1-mediated alternative splicing of cold-shock protein RBM3

    doi: 10.64898/2025.12.18.694734

    Figure Lengend Snippet: RBM3 PE skipping increases on destabilization of rG4 structures. See also Figure S1 (A) Schematic of the experimental design in i3-neurons to evaluate the effect of TMPyP4 in RBM3 PE inclusion (B) RT-PCR of RBM3 mRNA (Exon 2–4) in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms. (C) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (B). (D) qRT-PCR quantifying the PSI values of RBM3 PE relative to RBM3 mRNA in i3-neurons at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM). (E) Schematic of the experimental design in HeLa to evaluate the effect of TMPyP4 in RBM3 PE inclusion (top). RT-PCR of RBM3 mRNA (Exon 2–4) in HeLa at 37°C or 32°C (72h) in the presence of increasing concentration of TMPyP4 (5-200 µM) showing the PE-included (red arrows) and PE-skipped (green arrow) isoforms (bottom). (F) Graph showing the PSI values of RBM3 PE which are calculated based on the intensity of PE-included (red arrows) and PE-skipped (green arrow) isoforms from (E). Data information: N = 3 biological replicates. Mean ± SEM; ns (not significant), *(P<0.05), **(P<0.01); ***(P<0.001); one-way ANOVA with multiple comparisons.

    Article Snippet: After 24h, the medium was replaced with fresh medium containing TMPyP4 (Merck-Sigma) at different concentrations (0, 5, 10, 25, 50, 100, or 200 nM).

    Techniques: Reverse Transcription Polymerase Chain Reaction, Concentration Assay, Quantitative RT-PCR

    Effects of TMPyP4 and TMPyP2 treatments on Thermotoga and Pseudothermotoga growth, protein content, and ribosomal gene expression. ( A ) Schematic representation of the experimental setup, showing treatment with TMPyP4 or TMPyP2 and incubation for 6 and 24 h. ( B ) Bacterial growth measured as OD 600 after 6 and 24 h. ( C ) Total protein content after 6 and 24 h of treatment. Relative expression levels of ribosomal genes 5S ( D ), 16S ( E ), and 23S ( F ) determined by qPCR at 6 and 24 h post-treatment. Data are shown as mean ± standard error (SE). Statistical significance is indicated as * P < 0.05, ** P < 0.01, *** P < 0.001 (Student's t test). Abbreviations: mar: T. maritima , elf: T. elfii .

    Journal: Nucleic Acids Research

    Article Title: G-quadruplex structures in 16S rRNA regions correlate with thermal adaptation in prokaryotes

    doi: 10.1093/nar/gkaf042

    Figure Lengend Snippet: Effects of TMPyP4 and TMPyP2 treatments on Thermotoga and Pseudothermotoga growth, protein content, and ribosomal gene expression. ( A ) Schematic representation of the experimental setup, showing treatment with TMPyP4 or TMPyP2 and incubation for 6 and 24 h. ( B ) Bacterial growth measured as OD 600 after 6 and 24 h. ( C ) Total protein content after 6 and 24 h of treatment. Relative expression levels of ribosomal genes 5S ( D ), 16S ( E ), and 23S ( F ) determined by qPCR at 6 and 24 h post-treatment. Data are shown as mean ± standard error (SE). Statistical significance is indicated as * P < 0.05, ** P < 0.01, *** P < 0.001 (Student's t test). Abbreviations: mar: T. maritima , elf: T. elfii .

    Article Snippet: To incubate with TMPyP4 (Frontier Scientific, USA), the compound was added to the annealed mixture at a final concentration of 20 μM and incubated overnight at 4°C, after which CD melting tests were conducted.

    Techniques: Expressing, Incubation

    Confirmation of antibacterial activity. A The antibacterial activities of NMM, TMPyP2, BRACO19, TMPyP4, and Thioflavin T against SAUSA300 were examined by measuring cell growth in terms of OD at 600 nm. B, C SAUSA300 cell growth assessed as CFU/mL ( B ); representative sheep-blood agar plates showing the appearance of colonies during CFU enumeration ( C ). D , E Comparative killing kinetics of vancomycin (Van), Tetracycline (Tet), and NMM against SAUSA300 based on CFU/mL at 1.0 × ( D ); and 10 × ( E ) MIC of Van, Tet, NMM, and 0.05% Triton X-100 at different time points (0 to 12 h). F Comparative live/dead assay of SAUSA300 with 1 × MIC of NMM (5 µM) and Van (0.6 µM) using confocal microscopy, showing the proportion of live/dead SAUSA300 cells. SYTO9 and PI were used to stain the number of total and dead cells as green-fluorescent and red-fluorescent cells, respectively. All experiments were performed in triplicate and the average data was plotted with standard deviation. Significance of the data was analyzed using Student’s t -test. p -values less than 0.05 were considered significant (ns = non-significant p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.005, and **** p < 0.0001)

    Journal: Journal of Biomedical Science

    Article Title: Targeting the G-quadruplex as a novel strategy for developing antibiotics against hypervirulent drug-resistant Staphylococcus aureus

    doi: 10.1186/s12929-024-01109-3

    Figure Lengend Snippet: Confirmation of antibacterial activity. A The antibacterial activities of NMM, TMPyP2, BRACO19, TMPyP4, and Thioflavin T against SAUSA300 were examined by measuring cell growth in terms of OD at 600 nm. B, C SAUSA300 cell growth assessed as CFU/mL ( B ); representative sheep-blood agar plates showing the appearance of colonies during CFU enumeration ( C ). D , E Comparative killing kinetics of vancomycin (Van), Tetracycline (Tet), and NMM against SAUSA300 based on CFU/mL at 1.0 × ( D ); and 10 × ( E ) MIC of Van, Tet, NMM, and 0.05% Triton X-100 at different time points (0 to 12 h). F Comparative live/dead assay of SAUSA300 with 1 × MIC of NMM (5 µM) and Van (0.6 µM) using confocal microscopy, showing the proportion of live/dead SAUSA300 cells. SYTO9 and PI were used to stain the number of total and dead cells as green-fluorescent and red-fluorescent cells, respectively. All experiments were performed in triplicate and the average data was plotted with standard deviation. Significance of the data was analyzed using Student’s t -test. p -values less than 0.05 were considered significant (ns = non-significant p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.005, and **** p < 0.0001)

    Article Snippet: The G4 compounds were procured as BRACO19 trihydrochloride (GC50140, GLPBIO); Quarfloxin or CX-3543 (A12380, AdooQ), TMPyP2 or meso-Tetra (3-pyridyl) porphine (T40846, Frontier Scientific), TMPyP4 tosylate (GC12092, GLPBIO), PDS or Pyridostatin trifluoroacetate salt (18013, Cayman Chemical), PhenDC3 trifluoromethanesulfonate (CS-7711, Chemscene), Thioflavin T (2390-54-7, MedChemExpress), Quinacrine dihydrochloride (69-05-6, MedChemExpress), N-methyl mesoporphyrin IX or NMM (GC44416, GLPBIO), and Quercetin (117-39-5, MedChemExpress) (Fig. S1).

    Techniques: Activity Assay, Live Dead Assay, Confocal Microscopy, Staining, Standard Deviation